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Abstract In the stereochemicai model proposed by Perutz 111, 
the Fe-His(F8) bond plays a significant role in the allosteric 
transition in hemoglobin and the resulting cooperativity in ligand 
binding. When this bond is ruptured, there is a loss in the trans- 
mission of the information concerning ligand binding; examples 
are Hb(NO)4 in the presence of inositol hexakisphosphate (IHP), 
or nickel substituted Hb hybrids which, despite being liganded, 
exhibit deoxy-like properties. To study the effects of the loss of 
the iron proximal histidine bond, we have engineered the 
a21~2(F8)H92A recombinant Hb. The replacement of the highly 
conserved proximal histidine F8 residue by an alanine results in 
a low affinity for the heme group and a loss of the allosteric 
properties; kinetics of CO recombination after photodissociation 
show only the rapid bimoleeular phase, characteristic of the high 
affinity R-state. However, a significant amount of deoxy (T- 
state) kinetics are observed after addition of external effectors 
such as IHP. The iron-histidine bond is apparently crucial for the 
heme-heme interaction, but the allosteric equilibrium may still be 
influenced by external constraints. 
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I. Introduction 
The stereochemical model proposed by Perutz [1] provides 
an elegant explanation for the hemoglobin (Hb) allosteric 
mechanism. The binding ofa ligand to the iron (with modifica- 
tion of its spin state) is the trigger of the Hb allosteric transition. 
Kinetic studies have shown that after photodissociation f the 
oxy form, the iron moves within picoseconds [2] towards the 
heme plane by at least 0.2 A compared to the deoxy Hb config- 
uration while the Fe-His (F8) bond is shortened by 0.2 A [3]. 
The resulting translation of the F helix is transmitted tothe au82 
allosteric interface leading to the modification of electrostatic 
contacts between the ~ C helix and the fl FG corner [4]. The 
Fe-His(FS) bond plays the role of an energetic conductor: when 
a ligand molecule binds to the heme, the chemical energy is 
distributed to the whole protein. As stated by Perutz [5] ' ... in 
the T structure nearly all the free energy is stored in the protein 
rather than in the heme, because the protein is softer and could 
*Corresponding author. Fax: (1) 46 70 64 46. 
Abbreviations: Hb, hemoglobin; IHP, inositol hexakisphosphate; L345, 
2-[4-(3,4,5-dichlorophenylureido)phenoxy]-2-methylpropionic acid; 
PP, protoporphyrin. 
take up strain energy in hydrogen bonds, Van der Waals inter- 
actions, and a variety of small torsions.' 
The rupture of the Fe-His(FS) bond has been observed for 
subunits of Hb(NO)4 in the presence of inositol hexa- 
phosphate (IHP) [6,7], in (aNi~Fe)2 metal substituted hemo- 
globin [8] or in (aNiflNi)/(aFeflFe) hybrid hemoglobins [9]. The 
breaking of the bond between the iron and the proximal histid- 
ine has also been observed in various carboxyl or nitrosylmyo- 
globins at low pH [10]. In hemoglobin the rupture induces a 
shift of the allosteric equilibrium towards the T structure. Inter- 
estingly the (aFeflPP)2 hybrid hemoglobin, where proto-por- 
phyrin without the metal atom is substituted for heme, binds 
oxygen cooperatively, contrary to the (aPPflFe)2 hybrid [11]. 
This last result raises the question concerning the pathways 
used by Hb to transmit the information of ligand binding to the 
other subunits. To study the role of the Fe-His(F8) bond in the 
cooperative oxygen binding, we prepared the artificial mutant 
af1292(F8)His~Ala (rHb flH92A). It was of interest o know 
whether cooperative oxygen binding still occurred espite the 
replacement of the proximal histidine residue by a small, non- 
polar alanine residue. 
Natural hemoglobin mutants at position F8 are unstable and 
exhibit functional characteristics of semi-hemoglobins, except 
for hemoglobins M: Hb Hyde Park fl(FS)H92Y and Hb Iwate 
~(F8)H87Y [12]. In these two hemoglobin variants the ferric 
iron is coordinated with the tyrosinate group [13]. This observa- 
tion suggests that there is a flexible distance between the por- 
phyrin plane and the F helix which can accommodate anaddi- 
tional hydroxyl group. In deoxy Hb the Fe-Cc~ F8 distance is 
equal to 6.5 A. Similarly in myoglobin (FS)H93G, the loss of 
the proximal histidine leads to a hole which can be occupied 
by various hindered bases such as imidazole [14]. 
We have recorded the static UV/visible absorbance and fluo- 
rescence spectra of the carbon monoxide and deoxy forms of 
recombinant Hb fl(FS)H92A to estimate the fraction of dehem- 
inized fl subunits. We have also measured CO recombination 
kinetics for this mutant o understand the influence of the loss 
of Fe-His(F8) bond in the fl subunits. 
2. Material and methods 
We produced the mutated fl-globin subunit using the pATPrTet [15] 
expression vector harboring afl synthetic coding sequence with optimal 
codon usage in Escherichia coli [16]. The mutational process is facili- 
tated by the different unique restriction sites placed along this coding 
sequence and consists of replacing the fragment cleaved by the corre- 
sponding synthetic oligonucleotides bearing the mutation. The 
pATPrTet expression vector directs the synthesis of the fusion protein 
CIIFX-fl globin under the control of the APr promoter. The cloned 
DNA was checked by complete sequencing. The use of a fusion CII 
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protein is justified by the need of NH2 terminal methionine removal 
[17]. The fl subunits were folded in the presence of cyanhemin and the 
partner carbonyl c~ subunits, prepared from natural HbA, to form the 
tetrameric Hb c~2flz [15]. The structure of the mutated chain was 
checked, after amino-ethylation, byhigh performance liquid chroma- 
tography (HPLC) of the tryptic digests and amino acid analysis of the 
mutated peptide. Cellulose acetate lectrophoresis of the mutant Hb at 
pH 8 was performed according to routine methods. All spectrophoto- 
metric studies were performed with a SLM-Aminco DW 2000. Fluores- 
cence studies were recorded using an SLM 8000 spectrofluorometer. 
Kinetics of CO recombination were recorded after flash photolysis by 
a 10 ns pulse providing 160 mJ at 532 nm (Quantel-Yag laser) [18]. 
Hemoglobin concentrations were determined from the absorbance at 
540 nm using an extinction coefficient for HbCO of 14.3 mM -~ cm -~ 
[19]. We used this wavelength because the extinction coefficient is sim- 
ilar for the carboxy form of ct and mutated fl subunits and Hb A. For 
Hb the globin and the heme contribute roughly equally to the absorb- 
ance at 280 nm. The fraction of deheminized mutated globin chains in 
rHb flH92A was estimated using an extinction coefficient of 16 mM -t 
cm -~ at 280 nm for the fl-globin. 
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Fig. 1. (A) Absorption spectrum of the carbonyl form of Hb A com- 
pared to that of rHb flH92A. The concentration f the HbCO samples 
was 5/IM (on a heme basis) in I00 mM phosphate buffer pH 7.0. 
(B) Absorption spectrum ofdeoxy Hb A and deoxy rHbflH92A, in 100 
mM phosphate buffer at pH7.0, 25°C, with 100/.tM Na dithionite. 
Subtraction of a 55% contribution of the Hb A spectrum, to estimate 
the spectrum for the mutant fl chain, revealed a large blue shift in the 
Soret band for the mutant subunit. 
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Fig. 2. Electrophoresis on cellulose acetate at alkaline pH. Two bands 
are present for rHb-CO flH92A (lane 3) migrating between HbCO A 
(lane l) and free or-CO chains. The addition of hemin-CN to the mutant 
Hb (lane 2) removes to a large extent the proportion of the more 
negative band. 
3.  Resu l t s  and  d i scuss ion  
The CO spectrum of rHb flH92A reveals a fraction of dehem- 
inized globin. For the same Soret absorption, the band at 280 
nm is increased for the mutant compared to normal Hb A (Fig. 
1A). The absorption ratio e420/e2s0 is lowered, from 5.2 for the 
native HbCO to 4.1 for the mutant, indicating a significant 
amount of apo-globin. This could also be due to a lower ab- 
sorption coefficient for the fl chain heine as a result of the 
perturbation in the heme pocket. This means that a large 
amount of mutant tetramers (about 40%) could be affected by 
at least one non-functional fl chain. Fluorescence results (data 
not shown) also suggest a loss of heme. The fluorescence spec- 
tra are a sensitive probe for the refolding of recombinant hemo- 
globins, since the fluorescent ryptophan residue is normally 
highly quenched by the heine. The fluorescence intensity for the 
mutant is 10-fold stronger than that observed for Hb A, indicat- 
ing heme loss. It decreases 2-fold upon addition of an excess 
of hemin suggesting hemin binding to at least half of the apo 
fl-globins. 
The deoxy spectra of Hb A and rHb flH92A are shown in 
Fig. lB. After normalization at 560 nm, the mutant's Soret 
band reveals a shift towards the blue and a larger bandwidth. 
This suggested the presence of two overlapping bands for the 
mutant. Assuming a normal spectrum for the c~ chains, we 
subtracted their contribution using the deoxy spectrum of Hb 
A. Note that since there is some heine loss from the fl chains, 
the observed spectrum should contain more than 50% contribu- 
tion of the normal deoxy spectrum. After subtraction of 55% 
of the Hb A spectrum, we obtained a well defined Soret band 
with peak at 423 nm (Fig. 1B). Spectra of deoxy heme in 
detergents, thought to produce the tetra-liganded form since 
water is eliminated as fifth ligand, show several peaks in the 
Soret band; thus the mutant fl chains are probably not tetra- 
coordinated. The fifth ligand is apparently not a histidine, as 
evidenced by the large blue shift. The spectrum is similar to that 
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of deoxy heine in co-solvents such as ethylene glycol or glycerol. 
The heme group in the deoxy mutant fl chains is most likely 
penta-coordinated with a weak ligand, possibly a water mole- 
cule. 
Fig. 2 shows the alkaline cellulose acetate lectrophoresis for 
the mutant. Two bands are seen migrating between ormal Hb 
A and ~ chains. The proportion of the more negative band 
greatly decreases upon addition of hemin-CN. This band is 
attributed to semi-Hb tetramers which are able to bind a heme, 
but apparently with a lower affinity than normal chains. 
Oxygen binding curves at equilibrium could not be per- 
formed due to the instability of the oxygenated form of the 
mutant rHb. The CO bimolecular kinetics for the mutant were 
measured before and after addition of heme-CO, in order to 
measure the functional properties of tetramers with 4 heroes. 
The CO bimolecular recombination kinetics of rHb flH92A are 
nearly monophasic with a CO association rate similar to that 
of R-state HbA (Fig. 3). Addition of heme-CO (up to 40% of 
the initial heme concentration) to saturate the globins did not 
change the R-like recombination kinetics. Parkurst et al. [20] 
have measured by the stopped flow technique the CO recombi- 
nation of a semi-Hb where only the c~ chains of ~2~2 tetramers 
bind the heme; the CO kinetics were rapid with a rate similar 
to that of isolated c~ chains. Since the rate of CO recombination 
for the R-state Hb is faster than that measured for isolated 
chains, we assume that a large fraction of mutant etramers 
contain 4 hemes. Under the same experimental conditions Hb 
A exhibits kinetics with 30% of a slow phase characteristic of
T-state tetramers (30-fold slower than the fast phase). The ratio 
of the two phases depends on the fraction of photodissociated 
heine-CO for Hb A but not for rHb flH92A. The bimolecular 
amplitude of the CO recombination is close to 50%, compara- 
ble to the value observed in carbonyl Hb A. This is consistent 
with the assumption of Hb (CO)4 being in the R-quaternary 
structure before the flash [21,22]. Therefore we conclude that 
tetrameric rHb flH92A is predominantly in the R-state and 
binds CO without cooperativity like other natural mutants at 
this position [12]. 
To test whether the cavity created by the fl(F8) H92A muta- 
tion can be filled by a proximal igand, we added 10 mM 
imidazole to the mutant Hb solution. The rates and amplitudes 
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Fig. 3. Bimolecular CO recombination kinetics for Hb A and rHb 
flH92A at 50% photodissociation n the absence or presence of0.2 mM 
IHP, plus or minus 0.1 mM L345. Additional heme-CO was added to 
the mutant Hb, since the spectroscopic studies indicated some heme 
loss. For details, see text. 
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Fig. 4. Bimolecular CO recombination kinetics for Hb A and rHb 
flH92A. The trace labeled HbA* represents the kinetics of CO recombi- 
nation to Hb A in the R-state, after 10% photodissociation. All other 
traces were obtained at 50% photodissociation. Solid lines are for Hb 
A. Dotted lines are for the rHb ~H92A with and without strong effec- 
tors IHP and L345. For details, see text. 
of the CO bimolecular kinetics for the mutant were not modi- 
fied by addition of imidazole. It is likely that the steric repulsion 
induced by the F8 methyl group of alanine impedes the bond 
between imidazole and the heme, since this bond is allowed by 
the mutation (FS) His--*Gly in myoglobin [14]. 
Addition of strong allosteric effectors inositol hexa- 
phosphate (IHP) and L345 restores an allosteric behavior for 
the rHb flH92A. These two allosteric effectors have distinct 
binding sites, between the fl chains for IHP and on the c~ chains 
for L345 [23], and their effects are additive. In these conditions 
the proportion of slow phase kinetics represents 30% with IHP 
alone, and 50% with IHP plus L345 (Fig. 3). Fig. 4 shows that 
the shift in the allosteric equilibrium due to the effector binding 
is smaller without addition of heine-CO to the mutant because 
of the presence of a semi-hemoglobin fraction. The proportion 
of rapid and slow kinetics for the tetramers with allosteric 
effectors is independent of the fraction photodissociation. This 
could be due either to a constant fraction of tetramers undergo- 
ing the allosteric transition or to a fixed fraction of tetramer in 
the T-state which rebinds CO with a slow rate, probably to the 
c~ subunits of the rHb flH92A. The bimolecular f action of CO 
recombination i creases by a few percent upon addition of 
effectors for normal and mutated hemoglobins indicating an 
R-quaternary structure before CO photodissociation [22]. 
While normal Hb A has a larger proportion of slow CO 
recombination i  the presence of IHP (70% for Hb A versus 
30% for the mutant), the influence of the allosteric effectors 
IHP and L345, for rHb flH92A, is similar. Both the mutant and 
Hb A (+ or - IHP) require a shift in the allosteric equilibrium 
of nearly an order of magnitude. 
In conclusion, the substitution of the highly conserved F8 
histidine by an alanine in the fl subunits of Hb A results in the 
loss of the tetramer allosteric properties and destabilizes the 
low affinity quaternary structure. This mutation probably mod- 
ifies to a large extent he proximal side of the heine pocket 
preventing the allosteric R---~T transition. The loss of the prox- 
imal Fe-His bond abolishes heme-heme interactions. However, 
allosteric effectors can still shift the allosteric equilibrium. We 
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suggest hat a pathway for control of the allosteric transition 
for this mutant still exists between the effector binding site and 
the ~f12 interface, in spite of the loss of interaction between the 
4 subunits via the Fe-His(F8) bond. 
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